文献速递肝病

磁共振成像去脂肌肉量预测失代偿期肝硬化患者慢加急性肝衰竭与生存

Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis.
PubMed 文献 · Hepatology · 2018-01-24

本研究在116例接受经颈静脉肝内门体分流术(TIPS)的肝硬化患者中,用磁共振成像测量去脂肌肉面积(FFMA)作为肌少症标志物,并在45例验证队列中确认。肌少症组TIPS后腹水或显性肝性脑病持续存在且死亡率更高,FFMA是生存的独立预测因子。

要点

  • FFMA与卵泡抑素及腰大肌厚度相关,与生存的关联略优于腰大肌厚度。
  • 已确定FFMA诊断肌少症的性别特异性截断值。
  • 肌少症组TIPS后无临床改善且死亡率更高,主要死于慢加急性肝衰竭。

核心结论

  • 本研究提供了一种易于应用的基于磁共振成像的去脂肌肉量测量方法,作为失代偿患者肌少症的标志物。
  • TIPS可能改善肌少症并从而提高生存,但TIPS后肌少症持续存在与TIPS应答降低及慢加急性肝衰竭发生和死亡风险更高相关。

研究设计与样本

  • 研究纳入116例肝硬化接受TIPS的患者,通过磁共振成像测量总竖脊肌面积和肌内脂肪组织面积并相减计算FFMA。
  • 训练队列71例比较CT测量的横断面腰大肌厚度与FFMA;15例在TIPS前后行MRI,12例进行卵泡抑素血清检测;结果在45例验证队列中确认。

主要发现

  • FFMA与卵泡抑素及横断面腰大肌厚度相关,且与生存的关联略优于横断面腰大肌厚度。
  • 肌少症组TIPS后失代偿(腹水、显性肝性脑病)持续存在,而非肌少症组消退。
  • 肌少症患者TIPS后无临床改善且死亡率更高,主要死于慢加急性肝衰竭。
  • FFMA是这些患者生存的独立预测因子。

关键数值与推荐

  • 已确定FFMA诊断肌少症的性别特异性截断值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Muscle mass seems to be a prognostic marker in patients with liver cirrhosis. However, reported methods to quantify muscle mass are heterogeneous, consented cutoff values are missing, and most studies have used computed tomography. This study evaluated fat-free muscle area (FFMA) as a marker of sarcopenia using magnetic resonance imaging (MRI) in patients with decompensated cirrhosis with transjugular intrahepatic portosystemic shunt (TIPS). The total erector spinae muscle area and the intramuscular fat tissue area were measured and subtracted to calculate the FFMA in 116 patients with cirrhosis by TIPS and MRI. The training cohort of 71 patients compared computed tomography-measured transversal psoas muscle thickness with FFMA. In 15 patients MRI was performed before and after TIPS, and in 12 patients follistatin serum measurements were carried out. The results on FFMA were confirmed in a validation cohort of 45 patients. FFMA correlated with follistatin and transversal psoas muscle thickness and showed slightly better association with survival than transversal psoas muscle thickness. Gender-specific cutoff values for FFMA were determined for sarcopenia. Decompensation (ascites, overt hepatic encephalopathy) persisted after TIPS in the sarcopenia group but resolved in the nonsarcopenia group. Sarcopenic patients showed no clinical improvement after TIPS as well as higher mortality, mainly due to development of acute-on-chronic liver failure. FFMA was an independent predictor of survival in these patients. CONCLUSION: This study offers an easy-to-apply MRI-based measurement of fat-free muscle mass as a marker of sarcopenia in decompensated patients; while TIPS might improve sarcopenia and thereby survival, persistence of sarcopenia after TIPS is associated with a reduced response to TIPS and a higher risk of acute-on-chronic liver failure development and mortality. (Hepatology 2018;67:1014-1026).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Praktiknjo M, Book M, Luetkens J, et al. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis. Hepatology. 2018. PMID: 29059469. doi:10.1002/hep.29602

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。